Epithelial Cell Function in the Progression of Periodontal Disease

上皮细胞在牙周病进展中的功能

基本信息

  • 批准号:
    8851566
  • 负责人:
  • 金额:
    $ 37.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Periodontal diseases are a class of inflammatory diseases which if left untreated can result in soft and hard tissue destruction. While microbes are etiological agents of periodontal disease, a harmful inflammatory response in a susceptible host can exacerbate disease. Oral epithelial cells are the first line of defense against microbial infection within the oral cavity. These important cells serve multiple roles at the mucosal surface including whereby they can function as non-hematopoietic innate immune cells (in contrast to traditional hematopoietic leukocytes) that contribute directly to innate immunity and play an important role in mucosal homeostasis. Over-activation of innate immunity or disruption of this homeostasis can result in initiation and/or exacerbation of localized inflammation as seen in periodontal diseases. Thus, it is imperative that we understand epithelial cell mediated regulation of immune responses to prevent and/or treat inflammation of oral mucosa. Dynamics of TLR signaling outcomes are attributable to several factors including the type of TLR ligand(s), concentration of TLR ligand(s), duration of stimulation by TLR ligand(s), and the cell type which is being engaged by TLR ligand(s). Indeed, our preliminary data demonstrates that both human and murine oral epithelial cells respond to TLR2 stimulation in a tolerogenic manner while TLR4 stimulation induces a pro- inflammatory phenotype. Here we present preliminary data whereby targeted, inducible knockout of MYD88 (a key TLR-signaling molecule) in oral epithelial cells exacerbated soft tissue infiltration and bone loss in a multi- microbial model of periodontal disease. We propose that MYD88-dependent signaling in oral epithelial cells plays a role in controlling inflammation thus limiting localized inflammation and averting periodontal disease. It is our hypothesis that oral epithelial cell MYD88-dependent TLR signaling causes tolerogenic immune tuning which counteracts otherwise inflammatory responses. Here we will delineate mechanisms of immune tuning by oral epithelial cells during periodontal disease initiation/progression. By establishing hallmarks of disease progression we will be able to delineate checkpoints at which novel interventions can be applied to halt or reverse periodontal disease inflammation. In addition, will delineate TLR-receptor usage and signaling events which contribute to regulatory versus inflammatory epithelial cell phenotypes, allowing for the identification of targets for novel interventions aimed at attenuating oral epithelial cell associaed inflammation. Finally, will determine in vivo efficacy of an anti- inflammatory agent in an oral epithelial cell dependent model of exacerbated periodontal disease and delineate the mechanism(s) of its regulation.
描述(由申请人提供):牙周疾病是一类炎症性疾病,如果未治疗,可能会导致软组织破坏。尽管微生物是牙周疾病的病因学药,但易感宿主的有害炎症反应会加剧疾病。口腔上皮细胞是针对口腔内微生物感染的第一道防线。这些重要细胞在粘膜表面发挥多种作用 包括它们可以用作非杂型先天性免疫细胞(与传统造血白细胞相比),这些细胞直接有助于先天免疫,并在粘膜稳态中起重要作用。过度激活先天免疫力或这种体内平衡的破坏可能导致牙周疾病中所见的局部炎症的启动和/或加剧。因此,我们必须了解上皮细胞介导的免疫反应调节以预防和/或治疗口服粘膜的炎症。 TLR信号传导结果的动力学归因于多种因素,包括TLR配体的类型,TLR配体的浓度,TLR配体刺激持续时间以及TLR配体参与的细胞类型。确实,我们的初步数据表明,人和鼠口腔上皮细胞都以耐受性方式对TLR2刺激反应,而TLR4刺激诱导了促炎性表型。在这里,我们提供了初步数据,在该数据中,在牙周疾病多微生物模型中,口腔上皮细胞中的MyD88(密钥TLR信号分子)的诱导型敲除(一种关键的TLR信号分子)加剧了软组织浸润和骨质流失。我们建议口腔上皮细胞中的MyD88依赖性信号传导在控制炎症中起作用,从而限制了局部炎症和避免牙周疾病。我们的假设是,口服上皮细胞MyD88依赖性TLR信号传导会导致耐受性免疫调节,从而抵消了其他炎症反应。在这里,我们将在牙周疾病开始/进展过程中描述口腔上皮细胞免疫调节的机制。通过建立疾病进展的标志,我们将能够描绘出可以将新干预措施应用于停止或反向牙周疾病炎症的检查站。此外,还将描绘有助于调节性和炎症性上皮细胞表型的TLR受体使用和信号传导事件,从而鉴定出旨在衰减口腔上皮细胞相关炎症的新型干预措施的靶标。最后,将确定抗炎症剂在口腔上皮细胞依赖性模型中的体内功效,并描述其调节的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shannon Margaret Wallet其他文献

Shannon Margaret Wallet的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shannon Margaret Wallet', 18)}}的其他基金

Project 3: Serological Interactions with the Mucosal Innate Immune System Regulates COVID-19 Associated Tissue Damage.
项目 3:血清学相互作用与粘膜先天免疫系统调节 COVID-19 相关组织损伤。
  • 批准号:
    10222246
  • 财政年份:
    2020
  • 资助金额:
    $ 37.5万
  • 项目类别:
Genetic regulation of intestinal epithelial cell innate immune signaling in human type 1 diabetes
人类1型糖尿病肠上皮细胞先天免疫信号的基因调控
  • 批准号:
    10047614
  • 财政年份:
    2018
  • 资助金额:
    $ 37.5万
  • 项目类别:
Epithelial Cell Function in the Progression of Periodontal Disease
上皮细胞在牙周病进展中的功能
  • 批准号:
    8666633
  • 财政年份:
    2013
  • 资助金额:
    $ 37.5万
  • 项目类别:
Epithelial Cell Function in the Progression of Periodontal Disease
上皮细胞在牙周病进展中的功能
  • 批准号:
    8560637
  • 财政年份:
    2013
  • 资助金额:
    $ 37.5万
  • 项目类别:
Aberrant immunological phenotypes/functions in the progression of early-onset AgP
早发性 AgP 进展中的异常免疫表型/功能
  • 批准号:
    7586001
  • 财政年份:
    2008
  • 资助金额:
    $ 37.5万
  • 项目类别:
Aberrant immunological phenotypes/functions in the progression of early-onset AgP
早发性 AgP 进展中的异常免疫表型/功能
  • 批准号:
    7694333
  • 财政年份:
    2008
  • 资助金额:
    $ 37.5万
  • 项目类别:

相似国自然基金

靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
  • 批准号:
    82273824
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
  • 批准号:
    82204218
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
  • 批准号:
    82103973
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
  • 批准号:
    10642598
  • 财政年份:
    2023
  • 资助金额:
    $ 37.5万
  • 项目类别:
Mechanisms of Metal Ion Homeostasis of Oral Streptococci
口腔链球菌金属离子稳态机制
  • 批准号:
    10680956
  • 财政年份:
    2023
  • 资助金额:
    $ 37.5万
  • 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
  • 批准号:
    10679628
  • 财政年份:
    2023
  • 资助金额:
    $ 37.5万
  • 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
  • 批准号:
    10696512
  • 财政年份:
    2023
  • 资助金额:
    $ 37.5万
  • 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 37.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了